Skip to main content
Erschienen in: European Radiology 12/2022

15.06.2022 | Breast

MRI characteristics of breast edema for assessing axillary lymph node burden in early-stage breast cancer: a retrospective bicentric study

verfasst von: Zeyan Xu, Yingying Ding, Ke Zhao, Chu Han, Zhenwei Shi, Yanfen Cui, Chunling Liu, Huan Lin, Xipeng Pan, Pinxiong Li, Minglei Chen, Huihui Wang, Xiaohui Deng, Changhong Liang, Yu Xie, Zaiyi Liu

Erschienen in: European Radiology | Ausgabe 12/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate whether breast edema characteristics at preoperative T2-weighted imaging (T2WI) could help evaluate axillary lymph node (ALN) burden in patients with early-stage breast cancer.

Methods

This retrospective study included women with clinical T1 and T2 stage breast cancer and preoperative MRI examination in two independent cohorts from May 2014 to December 2020. Low (< 3 LNs+) and high (≥ 3 LNs+) pathological ALN (pALN) burden were recorded as endpoint. Breast edema score (BES) was evaluated at T2WI. Univariable and multivariable analyses were performed by the logistic regression model. The added predictive value of BES was examined utilizing the area under the curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI).

Results

A total of 1092 patients were included in this study. BES was identified as the independent predictor of pALN burden in primary (n = 677) and validation (n = 415) cohorts. The analysis using MRI-ALN status showed that BES significantly improved the predictive performance of pALN burden (AUC: 0.65 vs 0.71, p < 0.001; IDI = 0.045, p < 0.001; continuous NRI = 0.159, p = 0.050). These results were confirmed in the validation cohort (AUC: 0.64 vs 0.69, p = 0.009; IDI = 0.050, p < 0.001; continuous NRI = 0.213, p = 0.047). Furthermore, BES was positively correlated with biologically invasive clinicopathological factors (p < 0.05).

Conclusions

In individuals with early-stage breast cancer, preoperative MRI characteristics of breast edema could be a promising predictor for pALN burden, which may aid in treatment planning.

Key Points

• In this retrospective study of 1092 patients with early-stage breast cancer from two cohorts, the MRI characteristic of breast edema has independent and additive predictive value for assessing axillary lymph node burden.
• Breast edema characteristics at T2WI positively correlated with biologically invasive clinicopathological factors, which may be useful for preoperative diagnosis and treatment planning for individual patients with breast cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chang JM, Leung JWT, Moy L et al (2020) Axillary nodal evaluation in breast cancer: state of the art. Radiology 295:500–515CrossRefPubMed Chang JM, Leung JWT, Moy L et al (2020) Axillary nodal evaluation in breast cancer: state of the art. Radiology 295:500–515CrossRefPubMed
2.
Zurück zum Zitat Giuliano AE (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575CrossRefPubMedPubMedCentral Giuliano AE (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Giuliano AE, Ballman KV, McCall L et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318:918–926CrossRefPubMedPubMedCentral Giuliano AE, Ballman KV, McCall L et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318:918–926CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Lyman GH, Somerfield MR, Bosserman LD et al (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 35:561–564 Lyman GH, Somerfield MR, Bosserman LD et al (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 35:561–564
5.
Zurück zum Zitat Brackstone M, Baldassarre FG, Perera FE et al (2021) Management of the axilla in early-stage breast cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline. J Clin Oncol 39:3056–3082CrossRefPubMed Brackstone M, Baldassarre FG, Perera FE et al (2021) Management of the axilla in early-stage breast cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline. J Clin Oncol 39:3056–3082CrossRefPubMed
6.
Zurück zum Zitat Dubsky P, Pinker K, Cardoso F et al (2021) Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. Lancet Oncol 22:e18–e28CrossRefPubMed Dubsky P, Pinker K, Cardoso F et al (2021) Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. Lancet Oncol 22:e18–e28CrossRefPubMed
7.
Zurück zum Zitat Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245:452–461CrossRefPubMedPubMedCentral Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245:452–461CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Krag D, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer — a multicenter validation study. N Engl J Med 339:941–946CrossRefPubMed Krag D, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer — a multicenter validation study. N Engl J Med 339:941–946CrossRefPubMed
9.
Zurück zum Zitat Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888CrossRefPubMed Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888CrossRefPubMed
10.
Zurück zum Zitat Pesek S, Ashikaga T, Krag LE, Krag D (2012) The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J Surg 36:2239–2251CrossRefPubMedPubMedCentral Pesek S, Ashikaga T, Krag LE, Krag D (2012) The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J Surg 36:2239–2251CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Byon JH, Park YV, Yoon JH et al (2021) Added value of MRI for invasive breast cancer including the entire axilla for evaluation of high-level or advanced axillary lymph node metastasis in the post–ACOSOG Z0011 trial era. Radiology 300:46–54CrossRefPubMed Byon JH, Park YV, Yoon JH et al (2021) Added value of MRI for invasive breast cancer including the entire axilla for evaluation of high-level or advanced axillary lymph node metastasis in the post–ACOSOG Z0011 trial era. Radiology 300:46–54CrossRefPubMed
12.
Zurück zum Zitat Panzironi G, Moffa G, Galati F et al (2020) Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner. Breast Cancer Res Treat 181:53–60CrossRefPubMed Panzironi G, Moffa G, Galati F et al (2020) Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner. Breast Cancer Res Treat 181:53–60CrossRefPubMed
13.
Zurück zum Zitat Cheon H, Kim HJ, Kim TH et al (2018) Invasive breast cancer: prognostic value of peritumoral edema identified at preoperative MR imaging. Radiology 287:68–75CrossRefPubMed Cheon H, Kim HJ, Kim TH et al (2018) Invasive breast cancer: prognostic value of peritumoral edema identified at preoperative MR imaging. Radiology 287:68–75CrossRefPubMed
14.
Zurück zum Zitat Uematsu T, Kasami M, Watanabe J (2014) Is evaluation of the presence of prepectoral edema on T2-weighted with fat-suppression 3 T breast MRI a simple and readily available noninvasive technique for estimation of prognosis in patients with breast cancer? Breast Cancer 21:684–692CrossRefPubMed Uematsu T, Kasami M, Watanabe J (2014) Is evaluation of the presence of prepectoral edema on T2-weighted with fat-suppression 3 T breast MRI a simple and readily available noninvasive technique for estimation of prognosis in patients with breast cancer? Breast Cancer 21:684–692CrossRefPubMed
15.
Zurück zum Zitat Uematsu T (2015) Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema. Breast Cancer 22:66–70CrossRefPubMed Uematsu T (2015) Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema. Breast Cancer 22:66–70CrossRefPubMed
16.
Zurück zum Zitat Harada TL, Uematsu T, Nakashima K et al (2021) Evaluation of breast edema findings at T2-weighted breast MRI is useful for diagnosing occult inflammatory breast cancer and can predict prognosis after neoadjuvant chemotherapy. Radiology 299:53–62CrossRefPubMed Harada TL, Uematsu T, Nakashima K et al (2021) Evaluation of breast edema findings at T2-weighted breast MRI is useful for diagnosing occult inflammatory breast cancer and can predict prognosis after neoadjuvant chemotherapy. Radiology 299:53–62CrossRefPubMed
17.
Zurück zum Zitat Liang T, Hu B, Du H, Zhang Y (2020) Predictive value of T2-weighted magnetic resonance imaging for the prognosis of patients with mass-type breast cancer with peritumoral edema. Oncol Lett 20:314CrossRefPubMedPubMedCentral Liang T, Hu B, Du H, Zhang Y (2020) Predictive value of T2-weighted magnetic resonance imaging for the prognosis of patients with mass-type breast cancer with peritumoral edema. Oncol Lett 20:314CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Abel MK, Greenwood H, Kelil T et al (2021) Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma. NPJ Breast Cancer 7:25 Abel MK, Greenwood H, Kelil T et al (2021) Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma. NPJ Breast Cancer 7:25
19.
Zurück zum Zitat Zhang X, Yang Z, Cui W et al (2021) Preoperative prediction of axillary sentinel lymph node burden with multiparametric MRI-based radiomics nomogram in early-stage breast cancer. Eur Radiol 31:5924–5939CrossRefPubMed Zhang X, Yang Z, Cui W et al (2021) Preoperative prediction of axillary sentinel lymph node burden with multiparametric MRI-based radiomics nomogram in early-stage breast cancer. Eur Radiol 31:5924–5939CrossRefPubMed
20.
Zurück zum Zitat Javid S, Segara D, Lotfi P et al (2010) Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy. Ann Surg Oncol 17:1841–1846CrossRefPubMed Javid S, Segara D, Lotfi P et al (2010) Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy. Ann Surg Oncol 17:1841–1846CrossRefPubMed
21.
Zurück zum Zitat Wang X, Chen L, Sun Y, Zhang B (2020) Evaluation of axillary lymph node metastasis burden by preoperative ultrasound in early-stage breast cancer with needle biopsy-proven metastasis. Clin Transl Oncol 22:468–473CrossRefPubMed Wang X, Chen L, Sun Y, Zhang B (2020) Evaluation of axillary lymph node metastasis burden by preoperative ultrasound in early-stage breast cancer with needle biopsy-proven metastasis. Clin Transl Oncol 22:468–473CrossRefPubMed
22.
Zurück zum Zitat Cheang MCU, Chia SK, Voduc D et al (2009) Ki67 Index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101:736–750 Cheang MCU, Chia SK, Voduc D et al (2009) Ki67 Index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101:736–750
23.
Zurück zum Zitat Goldhirsch A, Winer EP, Coates AS et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24:2206–2223CrossRefPubMedPubMedCentral Goldhirsch A, Winer EP, Coates AS et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24:2206–2223CrossRefPubMedPubMedCentral
24.
25.
Zurück zum Zitat Abe H (2021) Ongoing demand for radiologists in preoperative axillary lymph node assessment. Radiology 300:55–56CrossRefPubMed Abe H (2021) Ongoing demand for radiologists in preoperative axillary lymph node assessment. Radiology 300:55–56CrossRefPubMed
26.
Zurück zum Zitat Kataru RP, Ly CL, Shin J et al (2019) Tumor lymphatic function regulates tumor inflammatory and immunosuppressive microenvironments. Cancer Immunol Res 7:1345–1358CrossRefPubMedPubMedCentral Kataru RP, Ly CL, Shin J et al (2019) Tumor lymphatic function regulates tumor inflammatory and immunosuppressive microenvironments. Cancer Immunol Res 7:1345–1358CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Bae MS, Shin SU, Ryu HS et al (2016) Pretreatment MR imaging features of triple-negative breast cancer: association with response to neoadjuvant chemotherapy and recurrence-free survival. Radiology 281:392–400CrossRefPubMed Bae MS, Shin SU, Ryu HS et al (2016) Pretreatment MR imaging features of triple-negative breast cancer: association with response to neoadjuvant chemotherapy and recurrence-free survival. Radiology 281:392–400CrossRefPubMed
28.
Zurück zum Zitat Ahn HS, Jang M, Kim SM et al (2019) Usefulness of preoperative breast magnetic resonance imaging with a dedicated axillary sequence for the detection of axillary lymph node metastasis in patients with early ductal breast cancer. Radiol Med 124:1220–1228CrossRefPubMed Ahn HS, Jang M, Kim SM et al (2019) Usefulness of preoperative breast magnetic resonance imaging with a dedicated axillary sequence for the detection of axillary lymph node metastasis in patients with early ductal breast cancer. Radiol Med 124:1220–1228CrossRefPubMed
29.
Zurück zum Zitat Moradi B, Gity M, Etesam F et al (2020) Correlation of apparent diffusion coefficient values and peritumoral edema with pathologic biomarkers in patients with breast cancer. Clin Imaging 68:242–248CrossRefPubMed Moradi B, Gity M, Etesam F et al (2020) Correlation of apparent diffusion coefficient values and peritumoral edema with pathologic biomarkers in patients with breast cancer. Clin Imaging 68:242–248CrossRefPubMed
30.
Zurück zum Zitat Jiang M, Li C-L, Luo X-M et al (2022) Radiomics model based on shear-wave elastography in the assessment of axillary lymph node status in early-stage breast cancer. Eur Radiol 32:2313–2325CrossRefPubMed Jiang M, Li C-L, Luo X-M et al (2022) Radiomics model based on shear-wave elastography in the assessment of axillary lymph node status in early-stage breast cancer. Eur Radiol 32:2313–2325CrossRefPubMed
31.
Zurück zum Zitat Ha SM, Chang JM, Kim S-Y et al (2021) Prediction of axillary nodal burden in patients with invasive lobular carcinoma using MRI. Breast Cancer Res Treat 186:463–473CrossRefPubMed Ha SM, Chang JM, Kim S-Y et al (2021) Prediction of axillary nodal burden in patients with invasive lobular carcinoma using MRI. Breast Cancer Res Treat 186:463–473CrossRefPubMed
32.
Zurück zum Zitat Gao Y, Luo Y, Zhao C et al (2021) Nomogram based on radiomics analysis of primary breast cancer ultrasound images: prediction of axillary lymph node tumor burden in patients. Eur Radiol 31:928–937CrossRefPubMed Gao Y, Luo Y, Zhao C et al (2021) Nomogram based on radiomics analysis of primary breast cancer ultrasound images: prediction of axillary lymph node tumor burden in patients. Eur Radiol 31:928–937CrossRefPubMed
33.
Zurück zum Zitat Baltzer PAT, Yang F, Dietzel M et al (2010) Sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-mammography considering 974 histologically verified lesions: sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-mammography considering 974 histologically verified lesions. Breast J 16:233–239CrossRefPubMed Baltzer PAT, Yang F, Dietzel M et al (2010) Sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-mammography considering 974 histologically verified lesions: sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-mammography considering 974 histologically verified lesions. Breast J 16:233–239CrossRefPubMed
34.
Zurück zum Zitat Kettunen T, Okuma H, Auvinen P et al (2020) Peritumoral ADC values in breast cancer: region of interest selection, associations with hyaluronan intensity, and prognostic significance. Eur Radiol 30:38–46CrossRefPubMed Kettunen T, Okuma H, Auvinen P et al (2020) Peritumoral ADC values in breast cancer: region of interest selection, associations with hyaluronan intensity, and prognostic significance. Eur Radiol 30:38–46CrossRefPubMed
35.
Zurück zum Zitat Koyama H, Kobayashi N, Harada M et al (2008) Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis. Am J Pathol 172:179–193CrossRefPubMedPubMedCentral Koyama H, Kobayashi N, Harada M et al (2008) Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis. Am J Pathol 172:179–193CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Park NJ-Y, Jeong JY, Park JY et al (2021) Peritumoral edema in breast cancer at preoperative MRI: an interpretative study with histopathological review toward understanding tumor microenvironment. Sci Rep 11:12992CrossRefPubMedPubMedCentral Park NJ-Y, Jeong JY, Park JY et al (2021) Peritumoral edema in breast cancer at preoperative MRI: an interpretative study with histopathological review toward understanding tumor microenvironment. Sci Rep 11:12992CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Net JM, Whitman GJ, Morris E et al (2019) Relationships between human-extracted MRI tumor phenotypes of breast cancer and clinical prognostic indicators including receptor status and molecular subtype. Curr Probl Diagn Radiol 48:467–472CrossRefPubMed Net JM, Whitman GJ, Morris E et al (2019) Relationships between human-extracted MRI tumor phenotypes of breast cancer and clinical prognostic indicators including receptor status and molecular subtype. Curr Probl Diagn Radiol 48:467–472CrossRefPubMed
Metadaten
Titel
MRI characteristics of breast edema for assessing axillary lymph node burden in early-stage breast cancer: a retrospective bicentric study
verfasst von
Zeyan Xu
Yingying Ding
Ke Zhao
Chu Han
Zhenwei Shi
Yanfen Cui
Chunling Liu
Huan Lin
Xipeng Pan
Pinxiong Li
Minglei Chen
Huihui Wang
Xiaohui Deng
Changhong Liang
Yu Xie
Zaiyi Liu
Publikationsdatum
15.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 12/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-08896-z

Weitere Artikel der Ausgabe 12/2022

European Radiology 12/2022 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.